B

Encompass Health Corporation EHC

$123.47 $1.461.20% NYSE
Recommendation
Dividend Power Score
Prev Close
Volume
Avg Vol (90D)
Market Cap
Dividend & Yield
52-Week Range
P/E (TTM)
EPS (TTM)
Access our Premium Ratings
Get Access

Rating

Reward
Risk

Rating Factors

Growth Index
Efficiency Index
Solvency Index
Total Return Index
Volatility Index
Dividend Yield Index

Company Overview

Encompass Health Corporation (NYSE: EHC) is a U.S.-based healthcare services company focused primarily on post-acute care, with operations centered on inpatient rehabilitative treatment and home-based patient care services. The company operates in the healthcare and rehabilitation services industries and is widely recognized as one of the largest providers of inpatient rehabilitation in the United States. Its core revenue drivers are patient services delivered through its Inpatient Rehabilitation business and its former home health and hospice operations, which were historically conducted through Enhabit Home Health & Hospice prior to the separation of that business in 2022.

The company’s primary customer base includes patients recovering from strokes, neurological disorders, orthopedic injuries, cardiac conditions, and other debilitating illnesses or injuries requiring intensive rehabilitative care. Encompass Health’s strategic positioning is tied to its scale, national rehabilitation network, clinical specialization, and relationships with acute-care hospital systems and physicians. The company traces its origins to 1984 as HealthSouth Corporation, which initially focused on outpatient rehabilitation services before expanding into inpatient rehabilitation hospitals. Following governance and accounting scandals in the early 2000s, the company underwent restructuring and rebranding, ultimately becoming Encompass Health Corporation in 2018 to reflect its broader post-acute care focus.

Data compiled by narrative technology. May contain errors.
Sector

Income Statement

Total Revenue (TTM)
EBITDA (TTM)
EBIT (TTM)
Net Income (TTM)

Balance Sheet

Total Assets (Q)
Total Debt (Q)
Total Liabilities (Q)
Book Value Per Share (Q)

Cash Flow

Cash from Operations (TTM)
Cash from Investing (TTM)
Cash from Financing (TTM)
Net Change in Cash (TTM)

Filings

Filing Date
Friday, August 7, 2026
Period Date
Tuesday, June 30, 2026
Next Filing
Week of Oct 26 and 30 (est)

Price History

Loading...
52-Week Range87% of range
Low
$92.77
Current
$123.47
High
$127.99
Beta
7-Day Total Return
30-Day Total Return
60-Day Total Return
90-Day Total Return
Year to Date Total Return
1-Year Total Return
2-Year Total Return
3-Year Total Return
5-Year Total Return
52-week Low
52-week High

Valuation

Market Cap
Enterprise Value
Price/Sales (TTM)
Price/Book (Q)

Dividends and Shares

Shares Outstanding
Dividend Per Share (Most Recent)
Dividend Per Share (TTM)

Corporate Info

Phone Number
205 967 7116
Address
9001 Liberty Parkway
Birmingham, AL 35242
Country
Year Founded

Headlines

9/24/2026 - Zacks Investment Research